Detalhe da pesquisa
1.
Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly.
Clin Endocrinol (Oxf)
; 99(4): 378-385, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421211
2.
Diagnosis, treatment and follow-up of patients with acromegaly in a clinical practice setting in Spain: the ACROPRAXIS program Delphi survey.
Pituitary
; 23(2): 129-139, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31823249
3.
Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study.
Pituitary
; 22(2): 137-145, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30756345
4.
Supplementation for Performance and Health in Patients with Phenylketonuria: An Exercise-Based Approach to Improving Dietary Adherence.
Nutrients
; 16(5)2024 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38474766
5.
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study.
Eur J Endocrinol
; 190(6): 421-433, 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701338
6.
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.
Endocr Relat Cancer
; 31(7)2024 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713182
7.
Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA).
Pituitary
; 16(1): 115-21, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22481632
8.
Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly.
Endocrine
; 70(3): 575-583, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32725444
9.
A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess.
Clin Endocrinol (Oxf)
; 70(2): 192-200, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18702680
10.
Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study.
Endocrinol Nutr
; 63(8): 397-408, 2016 Oct.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-27448708
11.
[Practice guideline for diagnosis and treatment of craniopharyngioma and parasellar tumors of the pituitary gland]. / Guía práctica del manejo y tratamiento de los craneofaringiomas y otras lesiones paraselares.
Endocrinol Nutr
; 62(1): e1-13, 2015 Jan.
Artigo
em Espanhol
| MEDLINE | ID: mdl-25066506
12.
Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.
Endocrinology
; 155(11): 4329-40, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25137025
13.
[Neuroendocrinology in 2011]. / El año 2011 en Neuroendocrinología.
Endocrinol Nutr
; 59(5): 311-25, 2012 May.
Artigo
em Espanhol
| MEDLINE | ID: mdl-22425316